<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1995-11-01" modified="2020-10-07" version="204">
<accession>Q02078</accession>
<accession>B4DFQ7</accession>
<accession>F6XG23</accession>
<accession>O43814</accession>
<accession>Q14223</accession>
<accession>Q14224</accession>
<accession>Q59GX4</accession>
<accession>Q7Z6C9</accession>
<accession>Q96D14</accession>
<name>MEF2A_HUMAN</name>
<protein>
<recommendedName>
<fullName>Myocyte-specific enhancer factor 2A</fullName>
</recommendedName>
<alternativeName>
<fullName>Serum response factor-like protein 1</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">MEF2A</name>
<name type="synonym">MEF2</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1991" name="Genes Dev." volume="5" first="2327" last="2341">
<title>Human SRF-related proteins: DNA-binding properties and potential regulatory targets.</title>
<authorList>
<person name="Pollock R."/>
<person name="Treisman R."/>
</authorList>
<dbReference type="PubMed" id="1748287"/>
<dbReference type="DOI" id="10.1101/gad.5.12a.2327"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS MEF2; RSRFC4 AND RSRFC9)</scope>
<scope>DNA-BINDING</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>DIMERIZATION</scope>
<source>
<tissue>Placenta</tissue>
</source>
</reference>
<reference key="2">
<citation type="submission" date="1993-11" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Treisman R."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM RSRFC9)</scope>
<scope>SEQUENCE REVISION</scope>
</reference>
<reference key="3">
<citation type="journal article" date="1992" name="Genes Dev." volume="6" first="1783" last="1798">
<title>Human myocyte-specific enhancer factor 2 comprises a group of tissue-restricted MADS box transcription factors.</title>
<authorList>
<person name="Yu Y.-T."/>
<person name="Breitbart R.E."/>
<person name="Smoot L.B."/>
<person name="Lee Y."/>
<person name="Mahdavi V."/>
<person name="Nadal-Ginard B."/>
</authorList>
<dbReference type="PubMed" id="1516833"/>
<dbReference type="DOI" id="10.1101/gad.6.9.1783"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS MEF2 AND RSRFC9)</scope>
<scope>TISSUE SPECIFICITY</scope>
<source>
<tissue>Heart</tissue>
<tissue>Skeletal muscle</tissue>
</source>
</reference>
<reference key="4">
<citation type="submission" date="1996-02" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Suzuki E."/>
<person name="Lowry J."/>
<person name="Sonoda G."/>
<person name="Testa J.R."/>
<person name="Walsh K."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORMS RSRFC4 AND RSRFC9)</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 7)</scope>
<source>
<tissue>Amygdala</tissue>
</source>
</reference>
<reference key="6">
<citation type="submission" date="2005-03" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Totoki Y."/>
<person name="Toyoda A."/>
<person name="Takeda T."/>
<person name="Sakaki Y."/>
<person name="Tanaka A."/>
<person name="Yokoyama S."/>
<person name="Ohara O."/>
<person name="Nagase T."/>
<person name="Kikuno F.R."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 6)</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="7">
<citation type="journal article" date="2006" name="Nature" volume="440" first="671" last="675">
<title>Analysis of the DNA sequence and duplication history of human chromosome 15.</title>
<authorList>
<person name="Zody M.C."/>
<person name="Garber M."/>
<person name="Sharpe T."/>
<person name="Young S.K."/>
<person name="Rowen L."/>
<person name="O'Neill K."/>
<person name="Whittaker C.A."/>
<person name="Kamal M."/>
<person name="Chang J.L."/>
<person name="Cuomo C.A."/>
<person name="Dewar K."/>
<person name="FitzGerald M.G."/>
<person name="Kodira C.D."/>
<person name="Madan A."/>
<person name="Qin S."/>
<person name="Yang X."/>
<person name="Abbasi N."/>
<person name="Abouelleil A."/>
<person name="Arachchi H.M."/>
<person name="Baradarani L."/>
<person name="Birditt B."/>
<person name="Bloom S."/>
<person name="Bloom T."/>
<person name="Borowsky M.L."/>
<person name="Burke J."/>
<person name="Butler J."/>
<person name="Cook A."/>
<person name="DeArellano K."/>
<person name="DeCaprio D."/>
<person name="Dorris L. III"/>
<person name="Dors M."/>
<person name="Eichler E.E."/>
<person name="Engels R."/>
<person name="Fahey J."/>
<person name="Fleetwood P."/>
<person name="Friedman C."/>
<person name="Gearin G."/>
<person name="Hall J.L."/>
<person name="Hensley G."/>
<person name="Johnson E."/>
<person name="Jones C."/>
<person name="Kamat A."/>
<person name="Kaur A."/>
<person name="Locke D.P."/>
<person name="Madan A."/>
<person name="Munson G."/>
<person name="Jaffe D.B."/>
<person name="Lui A."/>
<person name="Macdonald P."/>
<person name="Mauceli E."/>
<person name="Naylor J.W."/>
<person name="Nesbitt R."/>
<person name="Nicol R."/>
<person name="O'Leary S.B."/>
<person name="Ratcliffe A."/>
<person name="Rounsley S."/>
<person name="She X."/>
<person name="Sneddon K.M.B."/>
<person name="Stewart S."/>
<person name="Sougnez C."/>
<person name="Stone S.M."/>
<person name="Topham K."/>
<person name="Vincent D."/>
<person name="Wang S."/>
<person name="Zimmer A.R."/>
<person name="Birren B.W."/>
<person name="Hood L."/>
<person name="Lander E.S."/>
<person name="Nusbaum C."/>
</authorList>
<dbReference type="PubMed" id="16572171"/>
<dbReference type="DOI" id="10.1038/nature04601"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 5 AND 8)</scope>
<source>
<tissue>Pancreas</tissue>
<tissue>Uterus</tissue>
</source>
</reference>
<reference key="9">
<citation type="journal article" date="1998" name="Nucleic Acids Res." volume="26" first="4771" last="4777">
<title>Interaction of myocyte enhancer factor 2 (MEF2) with a mitogen-activated protein kinase, ERK5/BMK1.</title>
<authorList>
<person name="Yang C.-C."/>
<person name="Ornatsky O.I."/>
<person name="McDermott J.C."/>
<person name="Cruz T.F."/>
<person name="Prody C.A."/>
</authorList>
<dbReference type="PubMed" id="9753748"/>
<dbReference type="DOI" id="10.1093/nar/26.20.4771"/>
</citation>
<scope>INTERACTION WITH MAPK7</scope>
<scope>PHOSPHORYLATION</scope>
</reference>
<reference key="10">
<citation type="journal article" date="1999" name="EMBO J." volume="18" first="5099" last="5107">
<title>HDAC4 deacetylase associates with and represses the MEF2 transcription factor.</title>
<authorList>
<person name="Miska E.A."/>
<person name="Karlsson C."/>
<person name="Langley E."/>
<person name="Nielsen S.J."/>
<person name="Pines J."/>
<person name="Kouzarides T."/>
</authorList>
<dbReference type="PubMed" id="10487761"/>
<dbReference type="DOI" id="10.1093/emboj/18.18.5099"/>
</citation>
<scope>INTERACTION WITH HDAC4 AND HDAC9</scope>
</reference>
<reference key="11">
<citation type="journal article" date="1999" name="Mol. Cell. Biol." volume="19" first="21" last="30">
<title>Regulation of the MEF2 family of transcription factors by p38.</title>
<authorList>
<person name="Zhao M."/>
<person name="New L."/>
<person name="Kravchenko V.V."/>
<person name="Kato Y."/>
<person name="Gram H."/>
<person name="di Padova F."/>
<person name="Olson E.N."/>
<person name="Ulevitch R.J."/>
<person name="Han J.-D."/>
</authorList>
<dbReference type="PubMed" id="9858528"/>
<dbReference type="DOI" id="10.1128/mcb.19.1.21"/>
</citation>
<scope>PHOSPHORYLATION AT THR-312; THR-319 AND SER-453</scope>
<scope>FUNCTION</scope>
<scope>HETERODIMERIZATION</scope>
<scope>MUTAGENESIS OF THR-312; THR-319; SER-355; SER-453 AND SER-479</scope>
</reference>
<reference key="12">
<citation type="journal article" date="1999" name="Mol. Cell. Biol." volume="19" first="4028" last="4038">
<title>Targeting of p38 mitogen-activated protein kinases to MEF2 transcription factors.</title>
<authorList>
<person name="Yang S.-H."/>
<person name="Galanis A."/>
<person name="Sharrocks A.D."/>
</authorList>
<dbReference type="PubMed" id="10330143"/>
<dbReference type="DOI" id="10.1128/mcb.19.6.4028"/>
</citation>
<scope>INTERACTION WITH MAPK14</scope>
<scope>PHOSPHORYLATION AT THR-312 AND THR-319</scope>
<scope>MUTAGENESIS OF ARG-269; LYS-270; LEU-273; VAL-275; ILE-277 AND PRO-278</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2000" name="J. Biol. Chem." volume="275" first="18534" last="18540">
<title>Big mitogen-activated kinase regulates multiple members of the MEF2 protein family.</title>
<authorList>
<person name="Kato Y."/>
<person name="Zhao M."/>
<person name="Morikawa A."/>
<person name="Sugiyama T."/>
<person name="Chakravortty D."/>
<person name="Koide N."/>
<person name="Yoshida T."/>
<person name="Tapping R.I."/>
<person name="Yang Y."/>
<person name="Yokochi T."/>
<person name="Lee J.D."/>
</authorList>
<dbReference type="PubMed" id="10849446"/>
<dbReference type="DOI" id="10.1074/jbc.m001573200"/>
</citation>
<scope>PHOSPHORYLATION AT THR-312; THR-319 AND SER-355</scope>
<scope>MUTAGENESIS OF THR-312; THR-319 AND SER-355</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2002" name="Proc. Natl. Acad. Sci. U.S.A." volume="99" first="3974" last="3979">
<title>Dominant-interfering forms of MEF2 generated by caspase cleavage contribute to NMDA-induced neuronal apoptosis.</title>
<authorList>
<person name="Okamoto S."/>
<person name="Li Z."/>
<person name="Ju C."/>
<person name="Scholzke M.N."/>
<person name="Mathews E."/>
<person name="Cui J."/>
<person name="Salvesen G.S."/>
<person name="Bossy-Wetzel E."/>
<person name="Lipton S.A."/>
</authorList>
<dbReference type="PubMed" id="11904443"/>
<dbReference type="DOI" id="10.1073/pnas.022036399"/>
</citation>
<scope>PROTEOLYTIC PROCESSING AT ASP-176; ASP-213 AND ASP-466</scope>
<scope>FUNCTION</scope>
<scope>MUTAGENESIS OF ASP-176 AND ASP-213</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2003" name="J. Biol. Chem." volume="278" first="15297" last="15303">
<title>Phosphorylation motifs regulating the stability and function of myocyte enhancer factor 2A.</title>
<authorList>
<person name="Cox D.M."/>
<person name="Du M."/>
<person name="Marback M."/>
<person name="Yang E.C.C."/>
<person name="Chan J."/>
<person name="Siu K.W.M."/>
<person name="McDermott J.C."/>
</authorList>
<dbReference type="PubMed" id="12586839"/>
<dbReference type="DOI" id="10.1074/jbc.m211312200"/>
</citation>
<scope>PHOSPHORYLATION AT SER-255; THR-312; THR-319 AND SER-408</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<scope>MUTAGENESIS OF SER-255</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2003" name="Neuron" volume="38" first="33" last="46">
<title>Cdk5-mediated inhibition of the protective effects of transcription factor MEF2 in neurotoxicity-induced apoptosis.</title>
<authorList>
<person name="Gong X."/>
<person name="Tang X."/>
<person name="Wiedmann M."/>
<person name="Wang X."/>
<person name="Peng J."/>
<person name="Zheng D."/>
<person name="Blair L.A.C."/>
<person name="Marshall J."/>
<person name="Mao Z."/>
</authorList>
<dbReference type="PubMed" id="12691662"/>
<dbReference type="DOI" id="10.1016/s0896-6273(03)00191-0"/>
</citation>
<scope>PHOSPHORYLATION AT SER-408</scope>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>MUTAGENESIS OF SER-408</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2003" name="Proc. Natl. Acad. Sci. U.S.A." volume="100" first="14725" last="14730">
<title>Regulation of the human GLUT4 gene promoter: interaction between a transcriptional activator and myocyte enhancer factor 2A.</title>
<authorList>
<person name="Knight J.B."/>
<person name="Eyster C.A."/>
<person name="Griesel B.A."/>
<person name="Olson A.L."/>
</authorList>
<dbReference type="PubMed" id="14630949"/>
<dbReference type="DOI" id="10.1073/pnas.2432756100"/>
</citation>
<scope>INTERACTION WITH SLC2A4RG</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2005" name="J. Biol. Chem." volume="280" first="28749" last="28760">
<title>Alternative pre-mRNA splicing governs expression of a conserved acidic transactivation domain in myocyte enhancer factor 2 factors of striated muscle and brain.</title>
<authorList>
<person name="Zhu B."/>
<person name="Ramachandran B."/>
<person name="Gulick T."/>
</authorList>
<dbReference type="PubMed" id="15834131"/>
<dbReference type="DOI" id="10.1074/jbc.m502491200"/>
</citation>
<scope>FUNCTION OF BETA DOMAIN</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2005" name="J. Neurosci." volume="25" first="4823" last="4834">
<title>Cyclin-dependent kinase 5 mediates neurotoxin-induced degradation of the transcription factor myocyte enhancer factor 2.</title>
<authorList>
<person name="Tang X."/>
<person name="Wang X."/>
<person name="Gong X."/>
<person name="Tong M."/>
<person name="Park D."/>
<person name="Xia Z."/>
<person name="Mao Z."/>
</authorList>
<dbReference type="PubMed" id="15888658"/>
<dbReference type="DOI" id="10.1523/jneurosci.1331-05.2005"/>
</citation>
<scope>PROTEOLYTIC PROCESSING</scope>
<scope>PHOSPHORYLATION</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2006" name="J. Cell. Mol. Med." volume="10" first="132" last="144">
<title>SUMO-1 modification of MEF2A regulates its transcriptional activity.</title>
<authorList>
<person name="Riquelme C."/>
<person name="Barthel K.K."/>
<person name="Liu X."/>
</authorList>
<dbReference type="PubMed" id="16563226"/>
<dbReference type="DOI" id="10.1111/j.1582-4934.2006.tb00295.x"/>
</citation>
<scope>SUMOYLATION AT LYS-403</scope>
<scope>INTERACTION WITH PIAS1</scope>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>MUTAGENESIS OF LYS-403</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2006" name="Proc. Natl. Acad. Sci. U.S.A." volume="103" first="45" last="50">
<title>PDSM, a motif for phosphorylation-dependent SUMO modification.</title>
<authorList>
<person name="Hietakangas V."/>
<person name="Anckar J."/>
<person name="Blomster H.A."/>
<person name="Fujimoto M."/>
<person name="Palvimo J.J."/>
<person name="Nakai A."/>
<person name="Sistonen L."/>
</authorList>
<dbReference type="PubMed" id="16371476"/>
<dbReference type="DOI" id="10.1073/pnas.0503698102"/>
</citation>
<scope>SUMOYLATION AT LYS-403</scope>
<scope>PHOSPHORYLATION AT SER-408</scope>
<scope>FUNCTION</scope>
<scope>MUTAGENESIS OF LYS-403 AND SER-408</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2006" name="Science" volume="311" first="1012" last="1017">
<title>A calcium-regulated MEF2 sumoylation switch controls postsynaptic differentiation.</title>
<authorList>
<person name="Shalizi A."/>
<person name="Gaudilliere B."/>
<person name="Yuan Z."/>
<person name="Stegmueller J."/>
<person name="Shirogane T."/>
<person name="Ge Q."/>
<person name="Tan Y."/>
<person name="Schulman B."/>
<person name="Harper J.W."/>
<person name="Bonni A."/>
</authorList>
<dbReference type="PubMed" id="16484498"/>
<dbReference type="DOI" id="10.1126/science.1122513"/>
</citation>
<scope>PHOSPHORYLATION AT SER-408</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2007" name="Mol. Cell. Biol." volume="27" first="7623" last="7630">
<title>Nemo-like kinase-myocyte enhancer factor 2A signaling regulates anterior formation in Xenopus development.</title>
<authorList>
<person name="Satoh K."/>
<person name="Ohnishi J."/>
<person name="Sato A."/>
<person name="Takeyama M."/>
<person name="Iemura S."/>
<person name="Natsume T."/>
<person name="Shibuya H."/>
</authorList>
<dbReference type="PubMed" id="17785444"/>
<dbReference type="DOI" id="10.1128/mcb.01481-07"/>
</citation>
<scope>PHOSPHORYLATION AT THR-312 BY NLK</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2008" name="Circulation" volume="118" first="934" last="946">
<title>Quantitative control of adaptive cardiac hypertrophy by acetyltransferase p300.</title>
<authorList>
<person name="Wei J.Q."/>
<person name="Shehadeh L.A."/>
<person name="Mitrani J.M."/>
<person name="Pessanha M."/>
<person name="Slepak T.I."/>
<person name="Webster K.A."/>
<person name="Bishopric N.H."/>
</authorList>
<dbReference type="PubMed" id="18697823"/>
<dbReference type="DOI" id="10.1161/circulationaha.107.760488"/>
</citation>
<scope>ACETYLATION</scope>
<scope>INVOLVEMENT IN CARDIAC HYPERTROPHY</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-98; SER-235 AND SER-255</scope>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-98 (ISOFORMS 6; MEFA AND RSRFC9)</scope>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-30 (ISOFORMS 7 AND 8)</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="26">
<citation type="journal article" date="2009" name="Science" volume="325" first="834" last="840">
<title>Lysine acetylation targets protein complexes and co-regulates major cellular functions.</title>
<authorList>
<person name="Choudhary C."/>
<person name="Kumar C."/>
<person name="Gnad F."/>
<person name="Nielsen M.L."/>
<person name="Rehman M."/>
<person name="Walther T.C."/>
<person name="Olsen J.V."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="19608861"/>
<dbReference type="DOI" id="10.1126/science.1175371"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-249</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2011" name="Mol. Med. Report." volume="4" first="465" last="469">
<title>Identification of HZF1 as a novel target gene of the MEF2 transcription factor.</title>
<authorList>
<person name="Liu X."/>
<person name="Jin E.Z."/>
<person name="Zhi J.X."/>
<person name="Li X.Q."/>
</authorList>
<dbReference type="PubMed" id="21468593"/>
<dbReference type="DOI" id="10.3892/mmr.2011.465"/>
</citation>
<scope>FUNCTION</scope>
<scope>CHROMATIN BINDING</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-98 AND SER-255</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="30">
<citation type="journal article" date="2004" name="Hum. Mol. Genet." volume="13" first="3181" last="3188">
<title>Transcription factor MEF2A mutations in patients with coronary artery disease.</title>
<authorList>
<person name="Bhagavatula M.R.K."/>
<person name="Fan C."/>
<person name="Shen G.-Q."/>
<person name="Cassano J."/>
<person name="Plow E.F."/>
<person name="Topol E.J."/>
<person name="Wang Q."/>
</authorList>
<dbReference type="PubMed" id="15496429"/>
<dbReference type="DOI" id="10.1093/hmg/ddh329"/>
</citation>
<scope>VARIANTS SER-263; LEU-279 AND ASP-283</scope>
<scope>CHARACTERIZATION OF VARIANTS SER-263; LEU-279 AND ASP-283</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2006" name="J. Med. Genet." volume="43" first="167" last="169">
<title>The Pro279Leu variant in the transcription factor MEF2A is associated with myocardial infarction.</title>
<authorList>
<person name="Gonzalez P."/>
<person name="Garcia-Castro M."/>
<person name="Reguero J.R."/>
<person name="Batalla A."/>
<person name="Ordonez A.G."/>
<person name="Palop R.L."/>
<person name="Lozano I."/>
<person name="Montes M."/>
<person name="Alvarez V."/>
<person name="Coto E."/>
</authorList>
<dbReference type="PubMed" id="15958500"/>
<dbReference type="DOI" id="10.1136/jmg.2005.035071"/>
</citation>
<scope>VARIANT LEU-279</scope>
<scope>ASSOCIATION WITH SUSCEPTIBILITY TO MYOCARDIAL INFARCTION</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2008" name="Circulation" volume="117" first="185" last="191">
<title>Lack of association between the MEF2A gene and myocardial infarction.</title>
<authorList>
<person name="Lieb W."/>
<person name="Mayer B."/>
<person name="Koenig I.R."/>
<person name="Borwitzky I."/>
<person name="Goetz A."/>
<person name="Kain S."/>
<person name="Hengstenberg C."/>
<person name="Linsel-Nitschke P."/>
<person name="Fischer M."/>
<person name="Doering A."/>
<person name="Wichmann H.E."/>
<person name="Meitinger T."/>
<person name="Kreutz R."/>
<person name="Ziegler A."/>
<person name="Schunkert H."/>
<person name="Erdmann J."/>
</authorList>
<dbReference type="PubMed" id="18086930"/>
<dbReference type="DOI" id="10.1161/circulationaha.107.728485"/>
</citation>
<scope>VARIANT LEU-279</scope>
<scope>LACK OF ASSOCIATION WITH MYOCARDIAL INFARCTION</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2000" name="EMBO J." volume="19" first="2615" last="2628">
<title>Solution structure of the MEF2A-DNA complex: structural basis for the modulation of DNA bending and specificity by MADS-box transcription factors.</title>
<authorList>
<person name="Huang K."/>
<person name="Louis J.M."/>
<person name="Donaldson L."/>
<person name="Lim F.L."/>
<person name="Sharrocks A.D."/>
<person name="Clore G.M."/>
</authorList>
<dbReference type="PubMed" id="10835359"/>
<dbReference type="DOI" id="10.1093/emboj/19.11.2615"/>
</citation>
<scope>STRUCTURE BY NMR OF 2-86 IN COMPLEX WITH DNA</scope>
</reference>
<reference key="34">
<citation type="journal article" date="2000" name="J. Mol. Biol." volume="297" first="437" last="449">
<title>Crystal structure of MEF2A core bound to DNA at 1.5 A resolution.</title>
<authorList>
<person name="Santelli E."/>
<person name="Richmond T.J."/>
</authorList>
<dbReference type="PubMed" id="10715212"/>
<dbReference type="DOI" id="10.1006/jmbi.2000.3568"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.5 ANGSTROMS) OF 2-78 IN COMPLEX WITH DNA</scope>
<scope>DIMERIZATION</scope>
</reference>
<comment type="function">
<text evidence="18 20 24 27 28 29 33 35">Transcriptional activator which binds specifically to the MEF2 element, 5'-YTA[AT](4)TAR-3', found in numerous muscle-specific genes. Also involved in the activation of numerous growth factor- and stress-induced genes. Mediates cellular functions not only in skeletal and cardiac muscle development, but also in neuronal differentiation and survival. Plays diverse roles in the control of cell growth, survival and apoptosis via p38 MAPK signaling in muscle-specific and/or growth factor-related transcription. In cerebellar granule neurons, phosphorylated and sumoylated MEF2A represses transcription of NUR77 promoting synaptic differentiation. Associates with chromatin to the ZNF16 promoter.</text>
</comment>
<comment type="subunit">
<text evidence="8 13 14 15 16 21 29 34">Binds DNA as a homo- or heterodimer. Dimerizes with MEF2D. Interacts with HDAC7 (By similarity). Interacts with PIAS1; the interaction enhances sumoylation. Interacts with HDAC4, HDAC9 and SLC2A4RG. Interacts (via the N-terminal) with MAPK7; the interaction results in the phosphorylation and transcriptional activity of MEF2A.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-2656305">
<id>Q02078</id>
</interactant>
<interactant intactId="EBI-1175243">
<id>Q99697-3</id>
<label>PITX2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-2656305">
<id>Q02078</id>
</interactant>
<interactant intactId="EBI-2639084">
<id>P70257-2</id>
<label>Nfix</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-15799584">
<id>Q02078-1</id>
</interactant>
<interactant intactId="EBI-80140">
<id>P63165</id>
<label>SUMO1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-16431401">
<id>Q02078-2</id>
</interactant>
<interactant intactId="EBI-2864512">
<id>P50221</id>
<label>MEOX1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-12232917">
<id>Q02078-5</id>
</interactant>
<interactant intactId="EBI-11953488">
<id>P56524-2</id>
<label>HDAC4</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-12232917">
<id>Q02078-5</id>
</interactant>
<interactant intactId="EBI-7116203">
<id>O75031</id>
<label>HSF2BP</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-16437973">
<id>Q02078-6</id>
</interactant>
<interactant intactId="EBI-1213983">
<id>Q13164</id>
<label>MAPK7</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="12 20 29">Nucleus</location>
</subcellularLocation>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>Q02078-1</id>
<name>MEF2</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>Q02078-2</id>
<name>MEFA</name>
<sequence type="described" ref="VSP_006240"/>
</isoform>
<isoform>
<id>Q02078-3</id>
<name>RSRFC4</name>
<sequence type="described" ref="VSP_006241 VSP_006242"/>
</isoform>
<isoform>
<id>Q02078-4</id>
<name>RSRFC9</name>
<sequence type="described" ref="VSP_006240 VSP_006241 VSP_006242"/>
</isoform>
<isoform>
<id>Q02078-5</id>
<name>5</name>
<sequence type="described" ref="VSP_006241"/>
</isoform>
<isoform>
<id>Q02078-6</id>
<name>6</name>
<sequence type="described" ref="VSP_006240 VSP_006241"/>
</isoform>
<isoform>
<id>Q02078-7</id>
<name>7</name>
<sequence type="described" ref="VSP_043338 VSP_006240"/>
</isoform>
<isoform>
<id>Q02078-8</id>
<name>8</name>
<sequence type="described" ref="VSP_046018 VSP_046019 VSP_006241"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="22 30">Isoform MEF2 and isoform MEFA are expressed only in skeletal and cardiac muscle and in the brain. Isoform RSRFC4 and isoform RSRFC9 are expressed in all tissues examined.</text>
</comment>
<comment type="PTM">
<text evidence="13 17 19 20 25 27 28 29 31 34 35">Constitutive phosphorylation on Ser-408 promotes Lys-403 sumoylation thus preventing acetylation at this site. Dephosphorylation on Ser-408 by PPP3CA upon neuron depolarization promotes a switch from sumoylation to acetylation on residue Lys-403 leading to inhibition of dendrite claw differentiation. Phosphorylation on Thr-312 and Thr-319 are the main sites involved in p38 MAPK signaling and activate transcription. Phosphorylated on these sites by MAPK14/p38alpha and MAPK11/p38beta, but not by MAPK13/p38delta nor by MAPK12/p38gamma. Phosphorylation on Ser-408 by CDK5 induced by neurotoxicity inhibits MEF2A transcriptional activation leading to apoptosis of cortical neurons. Phosphorylation on Thr-312, Thr-319 and Ser-355 can be induced by EGF.</text>
</comment>
<comment type="PTM">
<text evidence="8">Sumoylation on Lys-403 is enhanced by PIAS1 and represses transcriptional activity. Phosphorylation on Ser-408 is required for sumoylation. Has no effect on nuclear location nor on DNA binding. Sumoylated with SUMO1 and, to a lesser extent with SUMO2 and SUMO3. PIASx facilitates sumoylation in postsynaptic dendrites in the cerebellar cortex and promotes their morphogenesis (By similarity).</text>
</comment>
<comment type="PTM">
<text evidence="8">Acetylation on Lys-403 activates transcriptional activity. Acetylated by p300 on several sites in diffentiating myocytes. Acetylation on Lys-4 increases DNA binding and transactivation (By similarity). Hyperacetylation by p300 leads to enhanced cardiac myocyte growth and heart failure.</text>
</comment>
<comment type="PTM">
<text evidence="18 25">Proteolytically cleaved in cerebellar granule neurons on several sites by caspase 3 and caspase 7 following neurotoxicity. Preferentially cleaves the CDK5-mediated hyperphosphorylated form which leads to neuron apoptosis and transcriptional inactivation.</text>
</comment>
<comment type="disease">
<disease id="DI-01202">
<name>Coronary artery disease, autosomal dominant, 1</name>
<acronym>ADCAD1</acronym>
<description>A common heart disease characterized by reduced or absent blood flow in one or more of the arteries that encircle and supply the heart. Its most important complication is acute myocardial infarction.</description>
<dbReference type="MIM" id="608320"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="similarity">
<text evidence="42">Belongs to the MEF2 family.</text>
</comment>
<comment type="sequence caution" evidence="42">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="AAH53871" version="1"/>
</conflict>
<text>Truncated N-terminus.</text>
</comment>
<comment type="sequence caution" evidence="42">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="BAD92222" version="1"/>
</conflict>
<text>Extended N-terminus.</text>
</comment>
<dbReference type="EMBL" id="Y16312">
<property type="protein sequence ID" value="CAA76175.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="X63381">
<property type="protein sequence ID" value="CAA44979.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="X68503">
<property type="protein sequence ID" value="CAA48516.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="X68505">
<property type="protein sequence ID" value="CAA48517.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U49020">
<property type="protein sequence ID" value="AAB17195.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U44889">
<property type="protein sequence ID" value="AAB17195.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U49012">
<property type="protein sequence ID" value="AAB17195.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U49013">
<property type="protein sequence ID" value="AAB17195.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U49015">
<property type="protein sequence ID" value="AAB17195.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U49016">
<property type="protein sequence ID" value="AAB17195.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U49017">
<property type="protein sequence ID" value="AAB17195.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U49018">
<property type="protein sequence ID" value="AAB17195.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U49019">
<property type="protein sequence ID" value="AAB17195.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U49020">
<property type="protein sequence ID" value="AAB17196.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U44889">
<property type="protein sequence ID" value="AAB17196.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U49012">
<property type="protein sequence ID" value="AAB17196.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U49013">
<property type="protein sequence ID" value="AAB17196.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U49015">
<property type="protein sequence ID" value="AAB17196.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U49016">
<property type="protein sequence ID" value="AAB17196.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U49017">
<property type="protein sequence ID" value="AAB17196.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U49018">
<property type="protein sequence ID" value="AAB17196.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U49019">
<property type="protein sequence ID" value="AAB17196.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AK294207">
<property type="protein sequence ID" value="BAG57518.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AB208985">
<property type="protein sequence ID" value="BAD92222.1"/>
<property type="status" value="ALT_INIT"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AC015660">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AC022692">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AC103967">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC013437">
<property type="protein sequence ID" value="AAH13437.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC053871">
<property type="protein sequence ID" value="AAH53871.1"/>
<property type="status" value="ALT_INIT"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS45362.1">
<molecule id="Q02078-5"/>
</dbReference>
<dbReference type="CCDS" id="CCDS45363.1">
<molecule id="Q02078-7"/>
</dbReference>
<dbReference type="CCDS" id="CCDS53978.1">
<molecule id="Q02078-6"/>
</dbReference>
<dbReference type="CCDS" id="CCDS58401.1">
<molecule id="Q02078-8"/>
</dbReference>
<dbReference type="CCDS" id="CCDS81920.1">
<molecule id="Q02078-2"/>
</dbReference>
<dbReference type="PIR" id="C39481">
<property type="entry name" value="C39481"/>
</dbReference>
<dbReference type="PIR" id="S25831">
<property type="entry name" value="S25831"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001124399.1">
<molecule id="Q02078-7"/>
<property type="nucleotide sequence ID" value="NM_001130927.2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001124400.1">
<molecule id="Q02078-8"/>
<property type="nucleotide sequence ID" value="NM_001130928.2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001165365.1">
<molecule id="Q02078-6"/>
<property type="nucleotide sequence ID" value="NM_001171894.2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001306135.1">
<molecule id="Q02078-2"/>
<property type="nucleotide sequence ID" value="NM_001319206.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_005578.2">
<molecule id="Q02078-5"/>
<property type="nucleotide sequence ID" value="NM_005587.3"/>
</dbReference>
<dbReference type="RefSeq" id="XP_011519883.1">
<property type="nucleotide sequence ID" value="XM_011521581.2"/>
</dbReference>
<dbReference type="RefSeq" id="XP_011519884.1">
<molecule id="Q02078-1"/>
<property type="nucleotide sequence ID" value="XM_011521582.2"/>
</dbReference>
<dbReference type="RefSeq" id="XP_011519888.1">
<property type="nucleotide sequence ID" value="XM_011521586.2"/>
</dbReference>
<dbReference type="RefSeq" id="XP_016877679.1">
<property type="nucleotide sequence ID" value="XM_017022190.1"/>
</dbReference>
<dbReference type="RefSeq" id="XP_016877680.1">
<molecule id="Q02078-1"/>
<property type="nucleotide sequence ID" value="XM_017022191.1"/>
</dbReference>
<dbReference type="PDB" id="1C7U">
<property type="method" value="NMR"/>
<property type="chains" value="A/B=2-86"/>
</dbReference>
<dbReference type="PDB" id="1EGW">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.50"/>
<property type="chains" value="A/B/C/D=2-78"/>
</dbReference>
<dbReference type="PDB" id="1LEW">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="B=269-280"/>
</dbReference>
<dbReference type="PDB" id="3KOV">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.90"/>
<property type="chains" value="A/B/I/J=2-91"/>
</dbReference>
<dbReference type="PDB" id="3MU6">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.43"/>
<property type="chains" value="A/B/C/D=2-70"/>
</dbReference>
<dbReference type="PDB" id="3P57">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.19"/>
<property type="chains" value="A/B/C/D/I/J=2-91"/>
</dbReference>
<dbReference type="PDB" id="6BYY">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="A/B/C/D=1-64, A/B/C/D=92-95"/>
</dbReference>
<dbReference type="PDB" id="6BZ1">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.97"/>
<property type="chains" value="A/B/C/D=1-64, A/B/C/D=92-95"/>
</dbReference>
<dbReference type="PDBsum" id="1C7U"/>
<dbReference type="PDBsum" id="1EGW"/>
<dbReference type="PDBsum" id="1LEW"/>
<dbReference type="PDBsum" id="3KOV"/>
<dbReference type="PDBsum" id="3MU6"/>
<dbReference type="PDBsum" id="3P57"/>
<dbReference type="PDBsum" id="6BYY"/>
<dbReference type="PDBsum" id="6BZ1"/>
<dbReference type="SMR" id="Q02078"/>
<dbReference type="BioGRID" id="110369">
<property type="interactions" value="59"/>
</dbReference>
<dbReference type="CORUM" id="Q02078"/>
<dbReference type="DIP" id="DIP-40711N"/>
<dbReference type="IntAct" id="Q02078">
<property type="interactions" value="42"/>
</dbReference>
<dbReference type="MINT" id="Q02078"/>
<dbReference type="STRING" id="9606.ENSP00000346389"/>
<dbReference type="iPTMnet" id="Q02078"/>
<dbReference type="PhosphoSitePlus" id="Q02078"/>
<dbReference type="BioMuta" id="MEF2A"/>
<dbReference type="EPD" id="Q02078"/>
<dbReference type="jPOST" id="Q02078"/>
<dbReference type="MassIVE" id="Q02078"/>
<dbReference type="MaxQB" id="Q02078"/>
<dbReference type="PaxDb" id="Q02078"/>
<dbReference type="PeptideAtlas" id="Q02078"/>
<dbReference type="PRIDE" id="Q02078"/>
<dbReference type="ProteomicsDB" id="28155"/>
<dbReference type="ProteomicsDB" id="58035">
<molecule id="Q02078-1"/>
</dbReference>
<dbReference type="ProteomicsDB" id="58036">
<molecule id="Q02078-2"/>
</dbReference>
<dbReference type="ProteomicsDB" id="58037">
<molecule id="Q02078-3"/>
</dbReference>
<dbReference type="ProteomicsDB" id="58038">
<molecule id="Q02078-4"/>
</dbReference>
<dbReference type="ProteomicsDB" id="58039">
<molecule id="Q02078-5"/>
</dbReference>
<dbReference type="ProteomicsDB" id="58040">
<molecule id="Q02078-6"/>
</dbReference>
<dbReference type="ProteomicsDB" id="58041">
<molecule id="Q02078-7"/>
</dbReference>
<dbReference type="Antibodypedia" id="3854">
<property type="antibodies" value="1026 antibodies"/>
</dbReference>
<dbReference type="DNASU" id="4205"/>
<dbReference type="Ensembl" id="ENST00000338042">
<molecule id="Q02078-6"/>
<property type="protein sequence ID" value="ENSP00000337202"/>
<property type="gene ID" value="ENSG00000068305"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000354410">
<molecule id="Q02078-5"/>
<property type="protein sequence ID" value="ENSP00000346389"/>
<property type="gene ID" value="ENSG00000068305"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000449277">
<molecule id="Q02078-8"/>
<property type="protein sequence ID" value="ENSP00000399460"/>
<property type="gene ID" value="ENSG00000068305"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000557785">
<molecule id="Q02078-6"/>
<property type="protein sequence ID" value="ENSP00000453441"/>
<property type="gene ID" value="ENSG00000068305"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000557942">
<molecule id="Q02078-2"/>
<property type="protein sequence ID" value="ENSP00000453095"/>
<property type="gene ID" value="ENSG00000068305"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000558812">
<molecule id="Q02078-7"/>
<property type="protein sequence ID" value="ENSP00000454120"/>
<property type="gene ID" value="ENSG00000068305"/>
</dbReference>
<dbReference type="GeneID" id="4205"/>
<dbReference type="KEGG" id="hsa:4205"/>
<dbReference type="UCSC" id="uc002bve.4">
<molecule id="Q02078-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="4205"/>
<dbReference type="DisGeNET" id="4205"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000068305.17"/>
<dbReference type="GeneCards" id="MEF2A"/>
<dbReference type="HGNC" id="HGNC:6993">
<property type="gene designation" value="MEF2A"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000068305">
<property type="expression patterns" value="Low tissue specificity"/>
</dbReference>
<dbReference type="MalaCards" id="MEF2A"/>
<dbReference type="MIM" id="600660">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="608320">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q02078"/>
<dbReference type="OpenTargets" id="ENSG00000068305"/>
<dbReference type="Orphanet" id="411969">
<property type="disease" value="NON RARE IN EUROPE: Metabolic syndrome"/>
</dbReference>
<dbReference type="PharmGKB" id="PA30731"/>
<dbReference type="eggNOG" id="KOG0014">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00940000156205"/>
<dbReference type="HOGENOM" id="CLU_022902_4_0_1"/>
<dbReference type="InParanoid" id="Q02078"/>
<dbReference type="KO" id="K09260"/>
<dbReference type="OMA" id="MMPPLHL"/>
<dbReference type="OrthoDB" id="729387at2759"/>
<dbReference type="PhylomeDB" id="Q02078"/>
<dbReference type="TreeFam" id="TF314067"/>
<dbReference type="PathwayCommons" id="Q02078"/>
<dbReference type="Reactome" id="R-HSA-198753">
<property type="pathway name" value="ERK/MAPK targets"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-525793">
<property type="pathway name" value="Myogenesis"/>
</dbReference>
<dbReference type="SignaLink" id="Q02078"/>
<dbReference type="SIGNOR" id="Q02078"/>
<dbReference type="BioGRID-ORCS" id="4205">
<property type="hits" value="4 hits in 897 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="MEF2A">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="Q02078"/>
<dbReference type="GeneWiki" id="Myocyte-specific_enhancer_factor_2A"/>
<dbReference type="GenomeRNAi" id="4205"/>
<dbReference type="Pharos" id="Q02078">
<property type="development level" value="Tbio"/>
</dbReference>
<dbReference type="PRO" id="PR:Q02078"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 15"/>
</dbReference>
<dbReference type="RNAct" id="Q02078">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000068305">
<property type="expression patterns" value="Expressed in heart and 241 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="Q02078">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q02078">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0000790">
<property type="term" value="C:nuclear chromatin"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005667">
<property type="term" value="C:transcription regulator complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0033613">
<property type="term" value="F:activating transcription factor binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003682">
<property type="term" value="F:chromatin binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001228">
<property type="term" value="F:DNA-binding transcription activator activity, RNA polymerase II-specific"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0003700">
<property type="term" value="F:DNA-binding transcription factor activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0000981">
<property type="term" value="F:DNA-binding transcription factor activity, RNA polymerase II-specific"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0035035">
<property type="term" value="F:histone acetyltransferase binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042826">
<property type="term" value="F:histone deacetylase binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0046982">
<property type="term" value="F:protein heterodimerization activity"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0019901">
<property type="term" value="F:protein kinase binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0000978">
<property type="term" value="F:RNA polymerase II cis-regulatory region sequence-specific DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="NTNU_SB"/>
</dbReference>
<dbReference type="GO" id="GO:0001085">
<property type="term" value="F:RNA polymerase II transcription factor binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0000977">
<property type="term" value="F:RNA polymerase II transcription regulatory region sequence-specific DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043565">
<property type="term" value="F:sequence-specific DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0046332">
<property type="term" value="F:SMAD binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008134">
<property type="term" value="F:transcription factor binding"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0000976">
<property type="term" value="F:transcription regulatory region sequence-specific DNA binding"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0006915">
<property type="term" value="P:apoptotic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0061337">
<property type="term" value="P:cardiac conduction"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030154">
<property type="term" value="P:cell differentiation"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0071277">
<property type="term" value="P:cellular response to calcium ion"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0048813">
<property type="term" value="P:dendrite morphogenesis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0070375">
<property type="term" value="P:ERK5 cascade"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007507">
<property type="term" value="P:heart development"/>
<property type="evidence" value="ECO:0000270"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000165">
<property type="term" value="P:MAPK cascade"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000002">
<property type="term" value="P:mitochondrial genome maintenance"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0048311">
<property type="term" value="P:mitochondrion distribution"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007517">
<property type="term" value="P:muscle organ development"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000122">
<property type="term" value="P:negative regulation of transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0010613">
<property type="term" value="P:positive regulation of cardiac muscle hypertrophy"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0046326">
<property type="term" value="P:positive regulation of glucose import"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0051149">
<property type="term" value="P:positive regulation of muscle cell differentiation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0045944">
<property type="term" value="P:positive regulation of transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006351">
<property type="term" value="P:transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0055005">
<property type="term" value="P:ventricular cardiac myofibril assembly"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="CDD" id="cd00265">
<property type="entry name" value="MADS_MEF2_like"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="DisProt" id="DP01925"/>
<dbReference type="Gene3D" id="3.40.1810.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="IDEAL" id="IID00240"/>
<dbReference type="InterPro" id="IPR022102">
<property type="entry name" value="HJURP_C"/>
</dbReference>
<dbReference type="InterPro" id="IPR033896">
<property type="entry name" value="MADS_MEF2-like"/>
</dbReference>
<dbReference type="InterPro" id="IPR002100">
<property type="entry name" value="TF_MADSbox"/>
</dbReference>
<dbReference type="InterPro" id="IPR036879">
<property type="entry name" value="TF_MADSbox_sf"/>
</dbReference>
<dbReference type="Pfam" id="PF12347">
<property type="entry name" value="HJURP_C"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00319">
<property type="entry name" value="SRF-TF"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR00404">
<property type="entry name" value="MADSDOMAIN"/>
</dbReference>
<dbReference type="SMART" id="SM00432">
<property type="entry name" value="MADS"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF55455">
<property type="entry name" value="SSF55455"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00350">
<property type="entry name" value="MADS_BOX_1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50066">
<property type="entry name" value="MADS_BOX_2"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0010">Activator</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0053">Apoptosis</keyword>
<keyword id="KW-0217">Developmental protein</keyword>
<keyword id="KW-0221">Differentiation</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-0238">DNA-binding</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0524">Neurogenesis</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0804">Transcription</keyword>
<keyword id="KW-0805">Transcription regulation</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="chain" description="Myocyte-specific enhancer factor 2A" id="PRO_0000199428">
<location>
<begin position="1"/>
<end position="507"/>
</location>
</feature>
<feature type="domain" description="MADS-box" evidence="12">
<location>
<begin position="3"/>
<end position="57"/>
</location>
</feature>
<feature type="DNA-binding region" description="Mef2-type" evidence="11">
<location>
<begin position="58"/>
<end position="86"/>
</location>
</feature>
<feature type="region of interest" description="Required for interaction with MAPKs">
<location>
<begin position="266"/>
<end position="283"/>
</location>
</feature>
<feature type="region of interest" description="Beta domain">
<location>
<begin position="289"/>
<end position="296"/>
</location>
</feature>
<feature type="compositionally biased region" description="Lys-rich (basic)">
<location>
<begin position="4"/>
<end position="31"/>
</location>
</feature>
<feature type="compositionally biased region" description="Ser/Thr-rich">
<location>
<begin position="141"/>
<end position="186"/>
</location>
</feature>
<feature type="compositionally biased region" description="Gln/Pro-rich">
<location>
<begin position="420"/>
<end position="446"/>
</location>
</feature>
<feature type="site" description="Cleavage" evidence="42">
<location>
<begin position="176"/>
<end position="177"/>
</location>
</feature>
<feature type="site" description="Cleavage" evidence="42">
<location>
<begin position="213"/>
<end position="214"/>
</location>
</feature>
<feature type="site" description="Cleavage" evidence="42">
<location>
<begin position="466"/>
<end position="467"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by CK2" evidence="8">
<location>
<position position="59"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="5 7">
<location>
<position position="98"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="5">
<location>
<position position="235"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="6">
<location>
<position position="249"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by MAPK14" evidence="5 7 19">
<location>
<position position="255"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by MAPK7 and MAPK14" evidence="13 17 19 31 35">
<location>
<position position="312"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by NLK" evidence="13 17 19 31 35">
<location>
<position position="312"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by MAPK7 and MAPK14" evidence="13 17 19 35">
<location>
<position position="319"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by MAPK7" evidence="17">
<location>
<position position="355"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine; alternate" evidence="9">
<location>
<position position="403"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by CDK5" evidence="19 20 27 28">
<location>
<position position="408"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="10">
<location>
<position position="415"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by MAPK" evidence="35">
<location>
<position position="453"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate">
<location>
<position position="403"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 7." id="VSP_043338" evidence="36">
<location>
<begin position="19"/>
<end position="86"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 8." id="VSP_046018" evidence="38">
<original>VTFTKRKFGLMKKAYELSVLCDCEIALIIFNSSNKLFQYASTDM</original>
<variation>TLRKKGLNGCESPDADDYFEHSPLSEDRFSKLNEDSDFIFKRGP</variation>
<location>
<begin position="19"/>
<end position="62"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 8." id="VSP_046019" evidence="38">
<location>
<begin position="63"/>
<end position="132"/>
</location>
</feature>
<feature type="splice variant" description="In isoform MEFA, isoform RSRFC9, isoform 6 and isoform 7." id="VSP_006240" evidence="36 37 39 40 41">
<original>ALNKKEHRGCDSPDPDTSYVLTPHTEEKYKKINEEFDNMMRNHKIA</original>
<variation>TLRKKGLNGCESPDADDYFEHSPLSEDRFSKLNEDSDFIFKRGP</variation>
<location>
<begin position="87"/>
<end position="132"/>
</location>
</feature>
<feature type="splice variant" description="In isoform RSRFC4, isoform RSRFC9, isoform 5, isoform 6 and isoform 8." id="VSP_006241" evidence="37 38 39 40 41">
<location>
<begin position="289"/>
<end position="296"/>
</location>
</feature>
<feature type="splice variant" description="In isoform RSRFC4 and isoform RSRFC9." id="VSP_006242" evidence="37 39 40">
<location>
<begin position="420"/>
<end position="421"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs121918530." id="VAR_038407" evidence="23">
<original>N</original>
<variation>S</variation>
<location>
<position position="263"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs121918529." id="VAR_038408" evidence="23 26 32">
<original>P</original>
<variation>L</variation>
<location>
<position position="279"/>
</location>
</feature>
<feature type="sequence variant" id="VAR_038409" evidence="23">
<original>G</original>
<variation>D</variation>
<location>
<position position="283"/>
</location>
</feature>
<feature type="sequence variant" description="Loss of nuclear localization; 66% decrease in transcription activation; loss of synergistic activation by MEF2A and GATA1 through a dominant-negative mechanism." id="VAR_017743">
<location>
<begin position="440"/>
<end position="446"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes cleavage at sites 1 and 2 by caspase 3. Increased cleavage at site 3 by caspase 3." evidence="18">
<original>D</original>
<variation>A</variation>
<location>
<position position="176"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes cleavage at sites 2 and 3 by caspase 7." evidence="18">
<original>D</original>
<variation>A</variation>
<location>
<position position="213"/>
</location>
</feature>
<feature type="mutagenesis site" description="Slightly increased MEF2A protein level." evidence="19">
<original>S</original>
<variation>A</variation>
<location>
<position position="255"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreased MEF2A protein level." evidence="19">
<original>S</original>
<variation>D</variation>
<location>
<position position="255"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduced p38 alpha- and beta2-mediated transcriptional activity; when associated with A-270." evidence="13">
<original>R</original>
<variation>A</variation>
<location>
<position position="269"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduced p38 alpha- and beta2-mediated transcriptional activity; when associated with A-269." evidence="13">
<original>K</original>
<variation>A</variation>
<location>
<position position="270"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduced p38 alpha- and beta2-mediated transcriptional activity; when associated with A-275." evidence="13">
<original>L</original>
<variation>A</variation>
<location>
<position position="273"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduced p38 alpha- and beta2-mediated transcriptional activity; when associated with A-273." evidence="13">
<original>V</original>
<variation>A</variation>
<location>
<position position="275"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduced p38 alpha- and beta2-mediated transcriptional activity; when associated with A-278." evidence="13">
<original>I</original>
<variation>A</variation>
<location>
<position position="277"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduced p38 alpha- and beta2-mediated transcriptional activity; when associated with A-277." evidence="13">
<original>P</original>
<variation>A</variation>
<location>
<position position="278"/>
</location>
</feature>
<feature type="mutagenesis site" description="Greatly reduced p38-mediated phosphorylation. Abolishes p38-mediated transcriptional activation; when associated with A-319." evidence="17 35">
<original>T</original>
<variation>A</variation>
<location>
<position position="312"/>
</location>
</feature>
<feature type="mutagenesis site" description="Greatly reduced p38-mediated phosphorylation. Abolishes P38-mediated transcriptional activation; when associated with A-312." evidence="17 35">
<original>T</original>
<variation>A</variation>
<location>
<position position="319"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on p38-mediated transcriptional activity." evidence="17 35">
<original>S</original>
<variation>A</variation>
<location>
<position position="355"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on p38-mediated phosphorylation.">
<original>S</original>
<variation>A</variation>
<location>
<position position="387"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes sumoylation. No change in subcellular location nor in DNA binding. Loss of transcriptional repression." evidence="27 29">
<original>K</original>
<variation>R</variation>
<location>
<position position="403"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of sumoylation." evidence="20 27">
<original>S</original>
<variation>A</variation>
<location>
<position position="408"/>
</location>
</feature>
<feature type="mutagenesis site" description="Rescues sumoylation." evidence="20 27">
<original>S</original>
<variation>D</variation>
<location>
<position position="408"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on p38-mediated phosphorylation." evidence="35">
<original>S</original>
<variation>A</variation>
<location>
<position position="453"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on p38-mediated phosphorylation." evidence="35">
<original>S</original>
<variation>A</variation>
<location>
<position position="479"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 4; AAB17195/AAB17196." ref="4" evidence="42">
<location>
<position position="430"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="14"/>
<end position="38"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="42"/>
<end position="48"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="50"/>
<end position="52"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="54"/>
<end position="60"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="62"/>
<end position="71"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="77"/>
<end position="80"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="81"/>
<end position="90"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="5">
<location sequence="Q02078-2">
<position position="98"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="5">
<location sequence="Q02078-4">
<position position="98"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="5">
<location sequence="Q02078-6">
<position position="98"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="5">
<location sequence="Q02078-7">
<position position="30"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="5">
<location sequence="Q02078-8">
<position position="30"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1C7U"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1EGW"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3KOV"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3P57"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18669648"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19608861"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000250"/>
<evidence key="9" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q2MJT0"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q60929"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000255"/>
<evidence key="12" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00251"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10330143"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10487761"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10715212"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10835359"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10849446"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11904443"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12586839"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12691662"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14630949"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1516833"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15496429"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15834131"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15888658"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15958500"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16371476"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16484498"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16563226"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1748287"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17785444"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18086930"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21468593"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9753748"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9858528"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="14702039"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="1516833"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="1748287"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000303">
<source ref="2"/>
</evidence>
<evidence key="41" type="ECO:0000303">
<source ref="6"/>
</evidence>
<evidence key="42" type="ECO:0000305"/>
<sequence length="507" mass="54811" checksum="362BA4FBCC792CE2" modified="1995-11-01" version="1">MGRKKIQITRIMDERNRQVTFTKRKFGLMKKAYELSVLCDCEIALIIFNSSNKLFQYASTDMDKVLLKYTEYNEPHESRTNSDIVEALNKKEHRGCDSPDPDTSYVLTPHTEEKYKKINEEFDNMMRNHKIAPGLPPQNFSMSVTVPVTSPNALSYTNPGSSLVSPSLAASSTLTDSSMLSPPQTTLHRNVSPGAPQRPPSTGNAGGMLSTTDLTVPNGAGSSPVGNGFVNSRASPNLIGATGANSLGKVMPTKSPPPPGGGNLGMNSRKPDLRVVIPPSSKGMMPPLSEEEELELNTQRISSSQATQPLATPVVSVTTPSLPPQGLVYSAMPTAYNTDYSLTSADLSALQGFNSPGMLSLGQVSAWQQHHLGQAALSSLVAGGQLSQGSNLSINTNQNISIKSEPISPPRDRMTPSGFQQQQQQQQQQQPPPPPQPQPQPPQPQPRQEMGRSPVDSLSSSSSSYDGSDREDPRGDFHSPIVLGRPPNTEDRESPSVKRMRMDAWVT</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

